Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer?-Accredited Facilities in the United States.
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer?-Accredited Facilities in the United States. Cancers (Basel). 2024 Mar 06; 16(5).